Embla Medical hf (OCSE:EMBLA)
kr 34.9 -0.7 (-1.97%) Market Cap: 14.90 Bil Enterprise Value: 18.15 Bil PE Ratio: 31.53 PB Ratio: 2.82 GF Score: 71/100

Q3 2023 Ossur hf Earnings Call Transcript

Oct 24, 2023 / 07:00AM GMT
Release Date Price: kr29.3 (+2.99%)
Operator

Good day, and thank you for standing by. Welcome to the Ãssur Q3 2023 Results Call and Webcast. (Operator Instructions) Please note that today's conference is being recorded. I would now like to hand the conference over to your speaker, Mr. Sveinn Solvason, President and CEO. Please go ahead, sir.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you to the Ãssur investor conference call where we will cover the results for the third quarter. My name is Sveinn Solvason. I'm the President and CEO. And with me here today is Arna Sveinsdottir, our CFO. We will begin by going through the highlights of the quarter and end with our guidance for '23. A Q&A session will then follow.

If we start by going through some of the key takeaways here in quarter 3. I'm very pleased to report the continued strong sales reports. The growth was largely driven by volume growth in Prosthetics and our Patient Care business as well as a favorable solution mix where we are selling and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot